Journal
BMJ OPEN
Volume 5, Issue 3, Pages -Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/bmjopen-2014-006218
Keywords
-
Categories
Funding
- Swiss Heart Foundation
- Abbot AG, Switzerland
- AMGEN Switzerland AG, Switzerland
- Astra-Zeneca AG, Switzerland
- Bayer (Schweiz) AG, Switzerland
- Biotronik AG, Switzerland
- Bristol-Myers Squibb AG, Switzerland
- Daiichi-Sankyo/Lilly AG, Switzerland
- Johnson & Johnson AG-Cordis Division, Switzerland
- A Menarini AG, Switzerland
- Merck Sharp & Dohme-Chibret AG, Switzerland
- Medtronic AG, Switzerland
- Pfizer AG, Switzerland
- SISMedical AG, Switzerland
- St. Jude Medical, Switzerland
- Takeda Pharma AG, Switzerland
- Vascular Medical AG, Switzerland
Ask authors/readers for more resources
Objective: Compliance with guidelines is increasingly used to benchmark the quality of hospital care, however, very little is known on patients admitted with acute coronary syndromes (ACS) and treated palliatively. This study aimed to evaluate the baseline characteristics and outcomes of these patients. Design: Prospective cohort study. Setting: Eighty-two Swiss hospitals enrolled patients from 1997 to 2014. Participants: All patients with ACS enrolled in the AMIS Plus registry (n=45 091) were analysed according to three treatment groups: palliative treatment, defined as use of aspirin and analgesics only and no reperfusion; conservative treatment, defined as any treatment including antithrombotics or anticoagulants, heparins, P2Y(12) inhibitors, GPIIb/IIIa but no pharmacological or mechanical reperfusion; and reperfusion treatment (thrombolysis and/or percutaneous coronary intervention during initial hospitalisation). The primary outcome measure was in-hospital mortality and the secondary measure was 1-year mortality. Results: Of the patients, 1485 (3.3%) were palliatively treated, 11 119 (24.7%) were conservatively treated and 32 487 (72.0%) underwent reperfusion therapy. In 1997, 6% of all patients were treated palliatively and this continuously decreased to 2% in 2013. Baseline characteristics of palliative patients differed in comparison with conservatively treated and reperfusion patients in age, gender and comorbidities (all p<0.001). These patients had more in-hospital complications such as postadmission onset of cardiogenic shock (15.6% vs 5.2%; p<0.001), stroke (1.8% vs 0.8%; p=0.001) and a higher in-hospital mortality (25.8% vs 5.6%; p<0.001). The subgroup of patients followed 1 year after discharge (n= 8316) had a higher rate of reinfarction (9.2% vs 3.4%; p=0.003) and mortality (14.0% vs 3.5%; p<0.001). Conclusions: Patients with ACS treated palliatively were older, sicker, with more heart failure at admission and very high in-hospital mortality. While refraining from more active therapy may often constitute the most humane and appropriate approach, we think it is important to also evaluate these patients and include them in registries and outcome evaluations.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available